Shares of major vaccine manufacturers Moderna and BioNTech fell despite receiving positive ratings from Wolfe Research, highlighting broader market volatility in the biotech sector.

Analysts highlight the long-term growth potential of Moderna's oncology pipeline, particularly its experimental cancer vaccines, as a key driver for the company's stock performance.

Moderna's stock is rallying after Wolfe upgraded the company following a successful trial win for its cancer therapy. This positive news has extended the company's gains in the market.

An opinion piece criticizes Portuguese politician Luís Montenegro, stating he lacks interest in building a reformist political and social majority. The author suggests he could have chosen this path but never will.

Moderna is making a significant investment in its mRNA technology for the development of cancer vaccines. The company is focusing on this innovative approach, which Wall Street is closely watching for its potential in oncology.

Merck and Moderna announced that a personalized cancer vaccine showed promise in preventing the return and spread of melanoma in a large trial involving over 1,000 patients, offering new hope for cancer patients.

Moderna's stock has surged by 179% following positive developments regarding its melanoma therapy candidate, which is seen as rewriting the company's growth story.

Investors, who had largely written off Moderna, are now showing renewed interest following a significant cancer breakthrough announced by the company.

Moderna's advancements in cancer vaccine development have revitalized the company and the broader biotech sector. This breakthrough is seen as a significant step in bringing Moderna back from a challenging period.

Three American stocks are reportedly exhibiting a market setup similar to the one that preceded Moderna's 177% increase, drawing attention from investors.

Moderna's stock experienced a significant surge, soaring 129% over the past week. The performance was highlighted during comprehensive market coverage of the U.S. market close.

An overview of today's market highlights several prominent stocks including Moderna, Walmart, Coinbase, Deere, SpaceX, and Tesla, explaining their influence on current market trends.

A new mRNA cancer vaccine developed by Merck & Co. and Moderna Inc. continues to show promise in preventing melanoma recurrence, with a recent breakthrough suggesting it could usher in a new era of cancer vaccines.

Elon Musk expressed optimism about mRNA technology's potential after Moderna and Merck announced a cancer vaccine breakthrough. Following the news, MRNA stock experienced a significant drop of over 11% in premarket trading.

Moderna's stock experienced a significant 177% surge, contributing to a widespread rally across the biotechnology sector.

Tumultuous session puts further pressure on momentum trades that have been unsettled since AI-related stock sell-off

JD Sports stock experienced a significant plummet, contributing to the FTSE 100's drift despite gains from mining companies. Moderna's stock also saw a decline.

Moderna's stock has nearly tripled after its mRNA cancer treatment showed promising results, bringing back memories of the company's pandemic-era surge following years of struggle.

Why Moderna Stock’s Historic Surge Is a Big Lesson for Markets  Barron's

This report highlights the stocks experiencing the largest movements in premarket trading, featuring companies such as Walmart, Coinbase, and Moderna among others.

Moderna's stock experienced a significant surge following news that its vaccine-drug combination effectively slowed the recurrence of melanoma in trials.

Moderna's melanoma vaccine has achieved a significant win, presenting a large opportunity for the company amidst high market expectations for its future.

Moderna shares jump 175% on skin cancer trial success  The Times

Merck and Moderna announced that their collaborative cancer vaccine has shown promising signs in preventing the recurrence of melanoma in patients.

Moderna's stock saw a significant rise following news regarding its cancer vaccine, while Estee Lauder also rallied after reporting its latest earnings.

Moderna's stock experienced a significant surge following the release of positive trial data for its cancer vaccine. The promising results have boosted investor confidence in the company's oncology pipeline.

The Sweden Democrats (SD) party has put forward a proposal to establish a new form of state-run psychiatric homes, aiming to modernize mental healthcare facilities.

The inaugural Modernator Photo Fest is set to begin on World Photography Day, August 19, with an exhibition titled '200 Years Later…' at the Parobrod Cultural Institution, commemorating two centuries since the invention of photography.

Comobå, one of Lisbon's first modern coffee shops, is celebrating its eighth anniversary, having been inspired by a trip to New York and successfully introducing matcha to the city.

RocketLab's stock has risen due to increased interest in space-related ventures, while Moderna's shares have moved in response to developments concerning its flu shot, impacting overall stock movers.

An article discusses the concept of modern mothers, advocating for mothers to be "just" mothers, embracing their intuition, mistakes, and "exaggerations," while being magical, spontaneous, and free.

Moderna's stock experienced a reversal, closing lower after initially seeing gains during the trading day.

The U.S. FDA has granted approval for Moderna's mRNA flu vaccine, marking the first mRNA-based flu shot to receive such clearance. This approval is considered significant for future vaccine development.

Moderna's stock experienced a decline even after the company received a significant approval from the FDA.

Wall Street analysts are providing predictions on whether Moderna stock is expected to climb or sink, offering insights for investors.

Moderna's stock saw a significant increase following the company's announcement of a promising, first-of-its-kind Ebola vaccine.

Twenty-five years after their debut album "Is This It," The Strokes have released their new album "Reality Awaits," prompting questions about the band's evolution and the state of rock and roll.

A review of the healthcare sector in July shows strong performance from Regeneron and DexCom, while Moderna and managed-care stocks experienced a retreat.

Several major companies, including Apple, Amazon, Reddit, GoDaddy, and IES Holdings, experienced notable stock movements during premarket and midday trading.

A new practical and modern alternative is presented for increasing storage space on refrigerator doors, offering a functional solution beyond traditional magnets.

Celebrating 50 years since its publication, Wayne W. Dyer's 'Your Erroneous Zones' is examined for its enduring impact on modern self-help literature, having sold over 35 million copies and sparking both praise and criticism.

If you don't like traditional shower trays or floor-level Italian models, opt for this affordable, elegant, and easy-to-install alternative.

An earnings preview outlines what to expect from Moderna's upcoming financial report.

Jefferies anticipates an uneventful second-quarter report from Moderna, with investor focus likely shifting to upcoming key data readouts.

A market update provides information on the performance and status of stocks including Under Armour (UAA), Deere & Co (DE), Monster Beverage (MNST), and Moderna (MRNA).

RBC Capital has increased its price target for Moderna (MRNA), signaling a positive outlook for the pharmaceutical company's stock.

A modern villa in Istria is captivating with its elegant architecture, large glass surfaces, and carefully designed details. The property also features a century-old olive tree and is currently on sale.

An analysis is comparing quantum computing stocks like IonQ and Quantum Computing Inc., and cutting-edge pharma stocks like Moderna and Recursion, to determine which are better buys in 2026. The evaluation aims to guide investors in these rapidly evolving sectors.

Investors are evaluating Moderna stock as a potential buy following a significant win with the FDA, prompting analysis on its market prospects.

Moderna's stock surged by 15% as investors reacted positively to an update on the company's drug pipeline, fueling optimism about its future prospects.

A weekly roundup highlights significant developments in the healthcare sector, focusing on key updates from pharmaceutical companies Merck, Moderna, and Biogen.

Moderna's flu vaccine has received a unanimous endorsement from an FDA advisory panel, moving it closer to potential approval.

Moderna (MRNA) experienced a substantial rise in its stock value in anticipation of its upcoming Investor Day.

American Tourister is highlighted for offering top-rated cabin suitcases that are spacious, modern, and easy to carry, allowing travelers to avoid checking luggage.

Moderna's stock climbed 6% following news that the pharmaceutical company is preparing to launch three new vaccines. The announcement signals potential growth and expansion in its product pipeline.

The CEO of Moderna warns that Europe is unprepared for a new pandemic and faces risks from bioterrorism due to a lack of mRNA production capacity. The company is now focusing on cancer treatment and other therapies, highlighting the broader implications of vaccine manufacturing readiness.

June 14, 2013, marked the premiere of 'Man of Steel' in cinemas, a film that ushered in a new, modern, and darker era for the iconic superhero Superman.

The Latvian city of Liepāja is still without a modern, well-equipped library, with no funding yet secured for a new building or major renovations. The city council plans to hold a design competition in the future.

The head of the British Conservative party stated that modern Britain is the least racist country in the world, as the party plans to abolish rules requiring public institutions to promote equality.

La Moderna Apicultura, Spain's oldest honey shop, which began as a beehive factory in the early 20th century, was rescued by a carpentry workshop and is now a reference for Spanish honey, offering nearly 30 varieties.

A new book, 'El club de las modernas', sheds light on the previously untold history of Spain's first feminist club, the Lyceum Club Femenino, whose members were once labeled 'frivolous and dangerous' for their progressive ideals.

UBS has raised its valuation on Moderna, Inc., anticipating key pipeline catalysts that could impact the company's future performance.

Moderna and Merck have released encouraging data from their collaborative efforts on an mRNA-based cancer vaccine, generating optimism in the medical community.

Financial analysts argue that Moderna’s current market capitalization is disproportionately high compared to its actual revenue generation capabilities.

U.S. equity markets posted solid gains on Tuesday, driven primarily by a sharp rally in pharmaceutical giant Moderna alongside broader tech and healthcare strength.

Reuters examines how the experimental Merck/Moderna cancer vaccine functions and outlines the key scientific, logistical, and economic hurdles preventing its widespread clinical deployment.

U.S. Stocks Up as Treasury Buybacks Calm Bond Yields; Moderna Surges WSJ

The Sweden Democrats party is advocating for tougher laws to combat illegal labor practices in Sweden, aiming to address what they describe as 'modern slavery'.

This week's notable healthcare headlines focus on developments concerning Moderna, Merck, and Twist Bioscience, highlighting key updates in the sector.

Prime Minister Montenegro's criticism of the media, labeled 'modern censorship,' is seen as a political strategy to divert attention and overshadow government announcements. This prolongs a tense relationship with journalists.

A market news summary highlights a significant downturn in chip stocks, a rotation within the retail sector, and a historical development concerning Moderna.

Scientists are hopeful about a new mRNA cancer vaccine developed by Merck & Co. and Moderna Inc., which has shown success in preventing melanoma from returning. This development brings researchers closer to using vaccines to train the immune system to destroy cancer cells.

Moderna's mRNA cancer vaccine has shown promising success, generating significant hype in the pharmaceutical market. However, experts caution that this success may not necessarily translate to a boost for all other mRNA stocks.

The markets are experiencing significant chaos, with bonds, cryptocurrencies, and Moderna's performance identified as key factors contributing to the current volatility.

Moderna and Merck have reported a significant breakthrough in cancer vaccines, particularly for melanoma, which could lead to a new wave of treatments. The market reaction to Moderna's melanoma results has been noted as contrary to expectations.

Moderna's business recovery is reportedly taking shape, with analysts suggesting there may be further upside potential for the company's stock. The article reviews the factors contributing to its resurgence and future prospects.

U.S. markets experienced a decline on Thursday, with Moderna recording the most significant losses among companies.

Moderna and Merck & Co. have reported positive study results for a new cancer therapy, marking a potential significant advance in cancer treatment and drawing attention to the implications for vaccine skeptics.

Moderna's stock has seen a significant 170% increase, with analysis provided on the reasons behind this surge and its potential future trajectory.

BioNTech's stock experienced a significant 22% surge after positive news regarding Moderna's cancer vaccine, though the article questions the sustainability of these gains.

Moderna's stock has reached its most overbought level in history following an explosive surge of over 175%. This significant increase has led to substantial payouts for options lottery tickets.

A recent success in cancer vaccine development has reportedly restored Wall Street's confidence in Moderna.

The article discusses Donald Trump's investment in Moderna, suggesting it has seen significant returns.

CSL stock experienced a rally today, occurring within a broader market context where Moderna's stock doubled, gold prices rallied, and the dollar sank.

Moderna co-founder Robert Langer has become a billionaire again after the biotech giant announced favorable results from a late-stage trial of a cancer vaccine, causing shares to double in value and contributing to a rise in US stock markets.

Moderna's stock experienced a significant 160% surge, leading to an estimated $5 billion loss for investors who had bet against the company's shares.

Wall Street analysts have issued various ratings, including an upgrade for Moderna and a downgrade for Baidu. These calls reflect shifting expert opinions on several prominent companies across different sectors.

Moderna and Merck have announced a breakthrough in personalized cancer vaccines, with their melanoma vaccine succeeding in a large trial. Separately, the Faecal Immunochemical Test (FIT) has been hailed as a 'game changer' in the fight against colorectal cancer in western Jamaica.

A speech by Calimontenegro has sparked controversy, with discussions labeling it as 'modern censorship' and criticizing its lack of clear direction. The discourse surrounding the speech highlights its contentious nature and the strong reactions it has provoked.

Dyson is experiencing significant success with its range of modern and discounted robot and cordless vacuum cleaners, which are highly effective at cleaning floors.

RocketLab shares are higher following recent earnings from SpaceX, while Moderna shares are moving after its mRNA flu shot received US approval last week.

Lluís Bonet, who served as the parish priest of Gaudí's Sagrada Família temple for 25 years, and was considered one of the fathers of its modern construction, has passed away.

Piper Sandler has reiterated its stock rating for Moderna after the company received approval for its flu vaccine.

The U.S. Food and Drug Administration has given its approval for Moderna's mRNA-based influenza vaccine, marking a significant development in flu prevention.

A Portuguese drone captured by Russia is being used to illustrate the evolution of drone technology and its central role in modern conflicts.

Moderna has initiated the first human trial for its vaccine targeting the Bundibugyo strain of the Ebola virus.

Sexologist Ana Sierra highlights that the modern obsession with measuring sexual performance often overlooks the crucial question of whether the experience was truly enjoyable, emphasizing that sexual health is about presence, desire, freedom, and well-being.

The U.S. Food and Drug Administration is evaluating Moderna's mRNA-based flu vaccine, which could be the first of its kind on the market, a decision expected to impact the biotech industry.

Moderna has reiterated its target of up to 10% revenue growth for 2026 while simultaneously lowering its cash cost guidance to approximately $4 billion. The company also expects 55% of its second-half revenue in Q3, despite a norovirus trial missing an early metric.

An article highlights two major reasons to consider buying Moderna stock before July 31, focusing on investment opportunities related to the pharmaceutical company.

Almost a year and a half after construction began, the new stadium in Kranjčevićeva Street in Zagreb is nearing completion, set to become the city's new football center.

An engineer suggests that changes in automotive industry recommendations for thinner engine oils might come at the cost of engine longevity, despite their increasing prevalence in new vehicle specifications.

An analysis explores the implications of holding Moderna stock in the event of a market crash.

Moderna has won a deal with the European Union to supply up to 24 million doses of its RSV vaccine.

Moderna has announced the appointment of Michael McDonnell to its board of directors, leading to a retreat in the company's shares from a 52-week high.

Moderna stock is currently soaring, prompting discussions among investors about whether it is too late to buy shares. The significant increase reflects strong market confidence in the pharmaceutical company.

Moderna's stock has seen a significant surge following a unanimous FDA vote, but Wall Street's average price target suggests a substantial decline, creating a discrepancy for investors.

Moderna's stock experienced a significant spike after the company provided an update on its mRNA pipeline, signaling positive developments for investors.

The article analyzes Moderna's stock performance and potential investment value, considering several key approvals that the company anticipates in the near future.

Moderna has reportedly received a signal that is deemed crucial for investors to consider, potentially impacting the company's stock performance.

Investors are advised to keep an eye on Microsoft, Moderna, Micron Technology, and Amazon as key stocks to watch for trading on Wednesday.

Moderna is reportedly considering German production sites, potentially in response to BioNTech's plant closures, indicating a strategic move in its manufacturing capabilities.

Moderna's stock has seen a 94% increase this year, prompting questions about its performance compared to other vaccine companies like Pfizer and Novavax.

The iconic stripe pattern, originally created to protect sailors and later embraced by Coco Chanel, is being reinvented with a modern twist in contemporary fashion.

Más allá de la producción en serie, ganan espacio las colecciones de edición limitada.

This article discusses the historical context of the Arab revolt against the Ottoman army, highlighting the role of British deception and its significance in the eventual collapse of the Ottoman Empire.

Moderna's financial performance and its need to generate consistent profits are under examination, as the company navigates its post-pandemic business strategy.

Following the World Health Organization's declaration of a public health crisis due to the Bundibugyo virus outbreak in Africa, internet users are creating new conspiracy theories, questioning why Moderna announced its involvement in vaccine development six months before the Ebola outbreak.

A new mRNA melanoma vaccine from Merck and Moderna showed sustained benefits over five years, cutting the risk of cancer recurrence or death by nearly half.

Hong Kong-listed biotechnology firms see stock surges as they accelerate similar cancer vaccine programs following Moderna's breakthrough trial results.

Investment firm Wolfe Research has upgraded its rating on Moderna shares, citing strong prospects for the company's mRNA technology platform and upcoming clinical developments.

Pharmaceutical stocks Moderna and BioNTech have seen significant price increases as investors reassess the commercial viability and pipeline strength of messenger RNA therapies beyond vaccines.

Shares in Moderna recovered their value after experiencing a pullback, continuing market fluctuations driven by investor sentiment around its experimental cancer vaccine pipeline.

Moderna's stock fell by 7% as traders booked profits following a significant year-to-date surge, with BioNTech and Merck also experiencing declines. In contrast, Tracsis stock saw a notable surge in its value.

Moderna's stock experienced a dramatic surge, jumping 177% in a single day, attracting significant investor attention. This substantial increase highlights strong market confidence in the company.

Rising bond yields have rattled the market, leading to a significant decline in chip stocks. Despite the broader market impact, some analysts are maintaining their positions in favored AI and retail stocks.

A modern house located on a spacious plot in Rakovec, Croatia, is currently listed for sale at 349,000 euros.

Scientists are hopeful about a new mRNA cancer vaccine developed by Merck & Co. and Moderna Inc., which has shown success in preventing melanoma from returning and could usher in a new era of cancer vaccines. This development brings researchers closer to using vaccines to train the immune system to destroy cancer cells.

Barron's provides stock grades for Moderna Inc., offering an evaluation of the pharmaceutical company's stock performance and investment outlook.

Several prominent stocks, including Moderna, Robinhood, BJ's Wholesale, and Coinbase, are experiencing notable movements in midday trading.

Today's market activity is being significantly influenced by movements in bonds, cryptocurrencies, and the performance of Moderna stock, among other key factors.

The MEXC exchange has announced the listing of Ondo Tokenized Stock Moderna (MRNAON), aiming to expand access for investors to exposure in the U.S. biotech sector. This move allows for new ways to invest in traditional assets through tokenization.

Moderna and Merck have announced a significant breakthrough in their mRNA-based cancer vaccine, which has shown promising results in curbing melanoma, with Moderna's chairman discussing the development.

Moderna's significant short squeeze has created ripple effects, impacting the broader AI chip trade and market dynamics.

Walmart and Moderna were among the market cap stock movers on Thursday, with both companies experiencing significant activity. Other notable movers included Deere, CrowdStrike, and SpaceX.

Moderna co-founder Robert Langer has regained his billionaire status with a net worth of $1.7 billion, having previously turned down numerous high-paying job offers to pursue greater impact.

Moderna Stock: A Massive Oncology Breakthrough Changes Everything. Barron's

Moderna's stock shares declined as investors opted to secure profits after a recent surge driven by positive developments in its cancer vaccine research.

Moderna shares double after experimental mRNA cancer treatment passes key test

Moderna's stock price saw a substantial increase today, driven by undisclosed factors that positively impacted investor confidence.

Moderna, Merck, Micron, Marvell, Estée Lauder, and Honeywell Aerospace are among the stocks highlighted as significant drivers of today's market movements.

Moderna's stock has seen a significant increase after reporting positive results for its cancer vaccine. An analyst subsequently upgraded the company's stock rating.

Leerink analysts suggest that BioNTech's recent stock rally, spurred by a Moderna trial win, is likely to be short-lived.

Moderna and Merck announced that their melanoma therapy met its primary goal in a Phase 3 trial, leading to significant jumps in both companies' stock prices. Moderna's shares rocketed 93%, while Merck's rose 7% following the positive news.

The Sweden Democrats party is advocating for the establishment of a new form of state-run psychiatric homes, which party leader Jimmie Åkesson describes as a modern version of traditional mental hospitals.

Moderna CEO Stephane Bancel sold $28.7 million in shares, while Snap CTO Robert Murphy sold $21.6 million in company stock.

Montenegro's leader has criticized what he terms "modern censorship" and expressed a desire for a decade of development, drawing parallels to the era of former Portuguese President Cavaco Silva. He emphasized the importance of freedom of expression and economic growth.

The article explores whether Arbutus Biopharma Corporation can leverage its settlement with Moderna, Inc. into a long-term competitive advantage within the biotechnology sector.

A modern villa featuring a swimming pool and wellness facilities is currently listed for sale in Istria, with an asking price of 1.45 million Euros.

The inaugural Modernator Photo Fest, titled '200 Years Later,' took place at the UK Parobrod cultural institution.

Several stocks, including Sweetgreen, Airbnb, DraftKings, Trade Desk, Zillow, Peloton, Sandisk, and Moderna, are making significant moves in after-hours and premarket trading. These movements indicate investor reactions to recent news or earnings reports.

The U.S. Food and Drug Administration has approved Moderna's flu vaccine, leading to a significant increase in the company's stock value.

Moderna has received authorization to begin clinical trials in Canada for its Ebola vaccine. This vaccine targets a new strain of the virus that has caused numerous fatalities.

Gordan Jandroković, Speaker of the Croatian Parliament, described Operation Oluja as a crucial historical turning point for Croatia's independence and called for the continued development of a modern and democratic state.

A modern house with a swimming pool, located 200 meters from the sea in Privlaka, Croatia, is listed for sale at 700,000 euros.

Several companies, including AbbVie, Forum Energy, CNO Financial Group, and Colgate-Palmolive, have released their Q2 2026 earnings reports and provided financial forecasts. These reports detail revenue, EPS, and EBITDA expectations for the current and upcoming quarters.

Xiaomi is making waves with its highly functional, modern, and compact travel backpacks, which are proving popular for their practicality.

A session reviewed key activities and results in digitalization, with a focus on improving the recognition of electronic banking payment proofs, as Montenegro aims for a modern and efficient public administration.

This article analyzes Moderna's stock performance, which has soared nearly 90% thus far in 2026, and discusses whether it remains a viable investment.

The most modern house in Formentera, located in Ses Clotades, is a creation by architects Marià Castelló and Lorena Ruzafa, both born on the island, featuring rainwater harvesting and aerothermal energy.

The exhibition 'Ljudet av' at Moderna Museet Malmö explores the spatial and poetic potential of sound, showcasing how art can function as activism.

A modern house featuring four bedrooms and a large garden is currently listed for sale on the Croatian island of Krk.

Brussels has signed an agreement with Moderna for the purchase of mRESVIA RSV vaccines, which protect against respiratory diseases like bronchitis and pneumonia, particularly for at-risk groups.

This article presents five simple and stylish ideas for renovating a garden without undertaking major construction work. It offers practical advice for those looking to update their outdoor space easily.

Jim Cramer has offered his latest opinions on various stocks, including recommendations for AST SpaceMobile and Moderna, and commentary on companies like Dell, Micron, and Walmart. He also shared his views on the gold market and specific companies like Agnico Eagle and NextEra.

A woman is speaking out against the perceived 'scam' of modern relationships, arguing that happiness comes from commitment rather than constant 'flowing' or independence. She suggests that traditionalism is re-emerging as an alternative to the emptiness often found in modern relationship trends.

Moderna Museet's exhibition 'Nisabas hus' aims to explore figurative painting over recent decades, though a critic suggests it shies away from its own questions.

Moderna's stock experienced a downturn after a six-session winning streak.

US health advisors are reviewing a novel mRNA-based flu vaccine, the first of its kind, which utilizes the same technology as COVID-19 vaccines. Moderna is seeking approval for individuals aged 50 and older.

Ten original, modern, and simple ideas are presented for decorating the wall behind a sofa without resorting to traditional paintings.

US pharmaceutical company Moderna is looking to invest in Germany and has shown interest in acquiring facilities belonging to its former competitor, BioNTech, while also calling for improved conditions for pharmaceutical companies.

The stock market has reached new intraday highs, driven by widespread buying across various stocks. Moderna, in particular, hit a three-month high following an FDA review for its flu shot.

Moderna has appointed a new commercial chief as the company prepares for multiple product launches.

This article presents five functional and modern alternatives to traditional folding clothes drying racks. These options are designed to save space in small apartments while providing efficient drying solutions.

A modern, efficient, and portable alternative to fixed ceramic hobs is presented as a perfect solution for small kitchens, available at a special price.

TV4's 'Kalla fakta' program has revealed that Sweden Democrats leader Jimmie Åkesson's self-published book, 'Det moderna folkhemmet,' was sold in large quantities to the party's own subsidiary, raising questions of potential corruption.

Tone Hansen, currently the director of the Munchmuseet in Oslo, has been appointed as the new head of the Moderna Museet, a prominent modern art museum, marking a significant leadership change for the institution.

Moderna's stock (MRNA) saw a 7.5% increase in anticipation of significant updates scheduled for release next week, indicating investor optimism.

A new mRNA melanoma vaccine developed by Merck and Moderna has demonstrated sustained benefits over five years, significantly reducing the risk of cancer recurrence or death by almost half in trials.

A global race is underway to develop vaccines for various Ebola species, with IAVI, Moderna, and the University of Oxford actively working on new candidates amid increasing fears of potential outbreaks.